Mixed connective tissue disease: an overview.
Mixed connective tissue disease is characterized by overlapping features of classic connective tissue diseases and the presence of antibodies to ribonucleoprotein. Placement of this disorder among the classic disorders still remains controversial. The clinical features, prognosis, and therapeutic features of this syndrome are discussed in this report.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D002648:Child; D003080:Cold Temperature; D003937:Diagnosis, Differential; D005260:Female; D005385:Fingers; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D008947:Mixed Connective Tissue Disease / Q000175:diagnosis* / Q000628:therapy; D010353:Patient Education as Topic; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011247:Pregnancy; D011379:Prognosis; D011928:Raynaud Disease / Q000628:therapy; D012595:Scleroderma, Systemic / Q000175:diagnosis; D012907:Smoking
D000893:Anti-Inflammatory Agents; D010643:Phenoxybenzamine